Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 3511 AL 3525

Effect of comprehensive geriatric assessment intervention on serum S100β levels and clinical outcomes in patients with Alzheimer's disease

Wang DW, Qin XT, Wang G, Liu J, Xu YP, Tian Y, Liu B.

J Alzheimers Dis. 2025 Jul;106(2):686-694. doi: 10.1177/13872877251344544. Epub 2025 Jul 1.

RT-QuIC: a highly promising diagnostic method for neurodegenerative diseases-advantages and limitations

Koníčková D, Hraboš D, Menšíková K, Tučková L, Kaleta M, Strnad M, Colosimo C, Kaňovský P.

Front Neurol. 2025 May 27;16:1578252. doi: 10.3389/fneur.2025.1578252. eCollection 2025.

Manganese-Induced Parkinsonism: A Review of Etiologies and Treatments

Khindri NM, Maj MC.

Degener Neurol Neuromuscul Dis. 2025 Jun 6;15:65-79. doi: 10.2147/DNND.S482018. eCollection 2025.

Metabolic effects of deep brain stimulation in Parkinson's disease - a systematic review and meta-analysis

Węgrzynek-Gallina J, Chmiela T, Kasprzyk A, Borończyk M, Siuda J.

Neurol Neurochir Pol. 2025;59(4):338-353. doi: 10.5603/pjnns.100297. Epub 2025 Jun 11.

Tissue Stem Cell-Based Therapies in Parkinson's Disease: A Scoping Review of Therapeutic Mechanisms and Translational Outcomes

Cueva E, Wiesheu A, Sordo Z, González J, Falconi S, Rodas JA, Leon-Rojas JE.

Cells. 2025 Jun 1;14(11):822. doi: 10.3390/cells14110822.

Broken Balance: Emerging Cross-Talk Between Proteostasis and Lipostasis in Neurodegenerative Diseases

Tittelmeier J, Nussbaum-Krammer C.

Cells. 2025 Jun 4;14(11):845. doi: 10.3390/cells14110845.

Correction to: A new swallowing supplement for dysphagia in patients with Parkinson's disease

Oh E, Jee S, Kim BK, Lee JS, Cho K, Ahn S.

Neurol Sci. 2025 Aug;46(8):4101. doi: 10.1007/s10072-025-08285-6.

Striatal Dopamine Actions and Movement: Inferences from Parkinson Disease

Albin RL, Brissenden JA, Lee TG, Leventhal DK.

J Neurosci. 2025 Jun 11;45(24):e0022252025. doi: 10.1523/JNEUROSCI.0022-25.2025.

Motor fluctuations in Parkinson disease - a mini-review of emerging drugs

Gros P, Armengou Garcia L, Fox SH.

Expert Opin Emerg Drugs. 2025 Sep;30(3):179-190. doi: 10.1080/14728214.2025.2517582. Epub 2025 Jun 16.

The Role and Mechanisms of G protein-coupled receptors in Parkinson's disease

Jing Y, Yao P, Zhu H, Yu L, Lin Y, Kang D.

Neurol Sci. 2025 Sep;46(9):4121-4135. doi: 10.1007/s10072-025-08260-1. Epub 2025 Jun 11.

Combining immersive exergaming with physiotherapy in a specialized intensive Parkinson's disease rehabilitation program: a randomized controlled trial

Pimenta Silva D, Bouça-Machado R, Pona-Ferreira F, Lobo T, Cacho R, Anker R, Krakauer JW, Ferreira JJ.

J Neuroeng Rehabil. 2025 Jun 11;22(1):131. doi: 10.1186/s12984-025-01640-w.

Low/High Multi-Frequency Stimulation of the Subthalamic Nucleus Improves Verbal Fluency Maintaining Motor Control in Parkinson's Disease

Ricciardi L, Cucinotta F, Pegolo E, Abundes-Corona A, Ishihara B, Hossain I, Sawacha Z, Hart M, Pereira E, Morgante F, Fasano A.

Mov Disord. 2025 Sep;40(9):1892-1900. doi: 10.1002/mds.30254. Epub 2025 Jun 11.

Ruxolitinib Is an Effective Therapy for Ciltacabtagene Autoleucel-Associated Parkinsonism in Multiple Myeloma

Wirk B, Lim J.

J Hematol. 2025 Jun;14(3):146-151. doi: 10.14740/jh2046. Epub 2025 Apr 22.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias